The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Epidemiology of fragile X syndrome: A systematic review and meta‐analysis
Abstract
Prevalence estimates for fragile X syndrome vary considerably. This systematic review and meta‐analysis was conducted to provide an accurate prevalence estimate for this disorder using primary publications in PubMed, Embase, and the Cochrane library. Data were pooled using Bayesian fixed‐effects and random‐effects models. Primary analyses assessed the frequency of the full mutation and premutation in males and females in the total population (no bias against individuals with intellectual disability) and in female carriers of the premutation in normal populations (biased against individuals with intellectual disability), based on diagnosis by polymerase chain reaction or Southern blotting. A sensitivity analysis included studies using any diagnostic testing method and conference abstracts. Sixty‐eight recorded observations provided data for the primary (56 observations) and sensitivity (12 observations) analysis. Using the random‐effects model, frequency of the full mutation was 1.4 (95% CI: 0.1–3.1) per 10,000 males and 0.9 (95% CI: 0.0–2.9) per 10,000 females (1:7,143 and 1:11,111, respectively) in the total population. The premutation frequency was 11.7 (95% CI: 6.0–18.7) per 10,000 males and 34.4 (95% CI: 6.3–83.3) per 10,000 for females (1:855 and 1:291, respectively) in the total population. The prevalence of female carriers of the premutation in the normal population was 34.4 (95% CI: 8.9–60.3) per 10,000, or 1:291. Sensitivity analyses resulted in similar prevalence estimates but with wider heterogeneity. Prevalence estimates for the full mutation from this meta‐analysis are lower than those in previous reviews of fragile X syndrome epidemiological data. © 2014 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
General methods for monitoring convergence of iterative simulations
Brooks, S. P., & Gelman, A. (1998) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1998.10474787 · Cited by 6,045
WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility
Lunn, D. J., Thomas, A., Best, N., & Spiegelhalter, D. (2000) · Statistics and Computing · doi:10.1023/a:1008929526011 · Cited by 5,368
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
General Methods for Monitoring Convergence of Iterative Simulations
Brooks, S. P., & Gelman, A. (1998) · Journal of Computational and Graphical Statistics · doi:10.2307/1390675 · Cited by 1,946
Penetrance of the Fragile X–Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population
Jacquemont, S. (2004) · JAMA · doi:10.1001/jama.291.4.460 · Cited by 695
Primary ovarian insufficiency: a more accurate term for premature ovarian failure
Welt, C. K. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03073.x · Cited by 538
Premature ovarian failure in the fragile X syndrome
Sherman, S. L. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(200023)97:3<189::aid-ajmg1036>3.0.co;2-j · Cited by 437
Incidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA
Coffee, B., Keith, K., Albizua, I., Malone, T., Mowrey, J., Sherman, S. L., & Warren, S. T. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.09.007 · Cited by 436
Systematic review of outpatient services for chronic pain control.
McQuay, Moore, Eccleston, Morley, & Williams (1997) · Health Technology Assessment · doi:10.3310/hta1060 · Cited by 424
Tassone, F., Pan, R., Amiri, K., Taylor, A. K., & Hagerman, P. J. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070073 · Cited by 350
The fragile X prevalence paradox
Hagerman, P. J. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.059055 · Cited by 342
Fragile-X–Associated Tremor/Ataxia Syndrome (FXTAS) in Females with the FMR1 Premutation
Hagerman, R. J., Leavitt, B. R., Farzin, F., Jacquemont, S., Greco, C. M., Brunberg, J. A., Tassone, F., Hessl, D., Harris, S. W., Zhang, L., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/420700 · Cited by 325
Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics
Bagni, C., Tassone, F., Neri, G., & Hagerman, R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63141 · Cited by 321 · cited 1×
“Thus both women who carry an FM and a PM are at risk of having a child with FXS. Fragile X syndrome is associated with a considerable humanistic, caregiver, and economic burden [Bailey et al., 2009; Bailey et al., 2012; Sacco et al., 2013].”
BackgroundThe full mutation in the FMR–1 gene of male fragile X patients is absent in their sperm
Reyniers, E., Vits, L., De Boulle, K., Roy, B. V., Velzen, D. V., de Graaff, E., Verkerk, A. J. M. H., Jorens, H. Z. J., Darby, J. K., Oostra, B., et al. (1993) · Nature Genetics · doi:10.1038/ng0693-143 · Cited by 303
Dombrowski, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.4.371 · Cited by 289
Fragile X syndrome: Diagnostic and carrier testing
Sherman, S., Pletcher, B. A., & Driscoll, D. A. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000182468.22666.dd · Cited by 277
Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome
Krueger, D. D., & Bear, M. F. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-061109-134644 · Cited by 259
Fragile-X Carrier Screening and the Prevalence of Premutation and Full-Mutation Carriers in Israel
Toledano-Alhadef, H., Basel-Vanagaite, L., Magal, N., Davidov, B., Ehrlich, S., Drasinover, V., Taub, E., Halpern, G. J., Ginott, N., & Shohat, M. (2001) · The American Journal of Human Genetics · doi:10.1086/321974 · Cited by 228
de Vries, B. B. A., van den Ouweland, A. M. W., Mohkamsing, S., Duivenvoorden, H. J., Mol, E., Gelsema, K., Rijn, M. V., Halley, D. J. J., Sandkuijl, L. A., Oostra, B. A., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/515496 · Cited by 226
Fernandez-Carvajal, I., Walichiewicz, P., Xiaosen, X., Pan, R., Hagerman, P. J., & Tassone, F. (2009) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2009.080173 · Cited by 204
Prevalence of CGG expansions of the FMR1 gene in a US population‐based sample
Seltzer, M. M., Baker, M. W., Hong, J., Maenner, M., Greenberg, J., & Mandel, D. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32065 · Cited by 189
Population incidence and segregation ratios in the Martin‐Bell syndrome
Webb, T. P., Bundey, S. E., Thake, A. I., Todd, J., Opitz, J. M., & Reynolds, J. F. (1986) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320230151 · Cited by 185
Fragile X: A Family of Disorders
Chonchaiya, W., Schneider, A., & Hagerman, R. J. (2009) · Advances in Pediatrics · doi:10.1016/j.yapd.2009.08.008 · Cited by 171
Preventive Screening for the Fragile X Syndrome
TURNER, G. M., Robinson, H. M., Laing, S., & Purvis‐Smith, S. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609043151002 · Cited by 167
Murray, A. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.6.727 · Cited by 165
Expansion of an FMR1 Grey-Zone Allele to a Full Mutation in Two Generations
Fernandez-Carvajal, I., Lopez Posadas, B., Pan, R., Raske, C., Hagerman, P. J., & Tassone, F. (2009) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2009.080174 · Cited by 164
McLennan, Y., Polussa, J., Tassone, F., & Hagerman, R. (2011) · Current Genomics · doi:10.2174/138920211795677886 · Cited by 160
Bayesian Measures of Model Complexity and Fit
Spiegelhalter, D. J., Best, N. G., Carlin, B. P., & Van Der Linde, A. (2002) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00353 · Cited by 151
Prevalence of the fragile X syndrome in African‐Americans
Crawford, D. C., Meadows, K. L., Newman, J. L., Taft, L. F., Scott, E., Leslie, M., Shubeck, L., Holmgreen, P., Yeargin‐Allsopp, M., Boyle, C. A., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10427 · Cited by 150
Preconceptional and prenatal screening for fragile X syndrome: Experience with 40 000 tests
Berkenstadt, M., Ries‐Levavi, L., Cuckle, H., Peleg, L., & Barkai, G. (2007) · Prenatal Diagnosis · doi:10.1002/pd.1815 · Cited by 124
Exploring the Adult Life of Men and Women With Fragile X Syndrome: Results From a National Survey
Hartley, S. L., Seltzer, M. M., Raspa, M., Olmsted, M. G., Bishop, E. E., & Bailey, D. B. (2011) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-116.1.16 · Cited by 122
Targeted treatments for fragile X syndrome
Berry‐Kravis, E., Knox, A. T., & Hervey, C. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9074-7 · Cited by 114
Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond
Groß, C., Berry‐Kravis, E., & Bassell, G. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.137 · Cited by 114
Screening for fragile X syndrome: a literature review and modelling study
Song, F., Barton, P., Sleightholme, V., Yao, G., & Fry-Smith, A. (2003) · Health Technology Assessment · doi:10.3310/hta7160 · Cited by 114
Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies
Ryynänen, M., Heinonen, S. T., Makkonen, M., Kajanoja, E., Mannermaa, A., & Pertti, K. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200285 · Cited by 112
Godler, D. E., Tassone, F., Loesch, D. Z., Taylor, A. K., Gehling, F., Hagerman, R. J., Burgess, T., Ganesamoorthy, D., Hennerich, D., Gordon, L., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq037 · Cited by 110
Population studies of the fragile X: a molecular approach.
Jacobs, P. A., Bullman, H., Macpherson, J., Youings, S. A., Rooney, V., Watson, A., & Dennis, N. R. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.6.454 · Cited by 107
Hantash, F. M., Goos, D. M., Crossley, B., Anderson, B., Zhang, K., Sun, W., & Strom, C. M. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181fa9fad · Cited by 105
Fragile X carrier screening and FMR1 allele distribution in the Japanese population
Otsuka, S., Sakamoto, Y., Siomi, H., Itakura, M., Yamamoto, K., Matumoto, H., Sasaki, T., Kato, N., & Nanba, E. (2009) · Brain and Development · doi:10.1016/j.braindev.2008.12.015 · Cited by 96
Potential therapeutic interventions for fragile X syndrome
Levenga, J., de Vrij, F. M. S., Oostra, B. A., & Willemsen, R. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.08.005 · Cited by 96
Prevalence of the fragile‐X syndrome in mentally retarded boys in a Swedish county
Gustavson, K., son, H. B. K., Holmgren, G., Opitz, J. M., & Reynolds, J. F. (1986) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320230152 · Cited by 93
Committee Opinion No. 469: Carrier Screening for Fragile X Syndrome
(2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181fae884 · Cited by 91
Blomquist, H. K. S., Gustavson, K. H., Holmgren, G., Nordenson, I., & Pålsson-Stråe, U. (1983) · Clinical Genetics · doi:10.1111/j.1399-0004.1983.tb00092.x · Cited by 82
Frequency and stability of the fragile X premutation
Reiss, A. L., Kazazian, H. H., Krebs, C. M., McAughan, A., Boehm, C. D., Abrams, M. T., & Nelson, D. L. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.3.393 · Cited by 81
Health and Economic Consequences of Fragile X Syndrome for Caregivers
Bailey, D. B., Raspa, M., Bishop, E. E., Mitra, D., Martin, S. A., Wheeler, A., & Sacco, P. (2012) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e318272dcbc · Cited by 79
Eichler, E. E., Hammond, H. A., Macpherson, J., Ward, P. A., & Nelson, D. L. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.12.2199 · Cited by 75
Functional Skills of Individuals With Fragile X Syndrome: A Lifespan Cross-Sectional Analysis
Bailey, D. B., Raspa, M., Holiday, D. B., Bishop, E. E., & Olmsted, M. G. (2009) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-114.4.289-303 · Cited by 70
Screening for fragile X syndrome.
Murray, Cuckle, Taylor, & Hewison (1997) · Health Technology Assessment · doi:10.3310/hta1040 · Cited by 60
Prevalence of the fragile X syndrome in four birth cohorts of children of school age
K�hk�nen, M., Alitalo, T., Airaksinen, E. M., Matilainen, R., LAUNIALA, K., Autio, S., & Leisti, J. (1987) · Human Genetics · doi:10.1007/bf00284720 · Cited by 59
Tzeng, C., Tsai, L., Hwu, W., Lin, S., Chao, M., Jong, Y., Chu, S., Chao, W.-C., & Lu, C. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30528 · Cited by 58
An assessment of screening strategies for fragile X syndrome in the UK
Pembrey, M. E., Barnicoat, A. J., Carmichael, B., Bobrow, M., & TURNER, G. M. (2001) · Health Technology Assessment · doi:10.3310/hta5070 · Cited by 58
Incidence of Fragile X in 5,000 Consecutive Newborn Males
Rife, M. F., Bádenas, C., Mallolas, J., Jiménez, L., Cervera, R., Maya, A. C. L., Glover, G., Rivera, F., & Milà, M. (2003) · Genetic Testing · doi:10.1089/109065703322783725 · Cited by 56
Arinami, T., Asano, M., Kobayashi, K., Yanagi, H., & Hamaguchi, H. (1993) · Human Genetics · doi:10.1007/bf00216445 · Cited by 56
Fragile X syndrome carrier screening in the prenatal genetic counseling setting
Cronister, A., DiMaio, M. S., Mahoney, M. J., Donnenfeld, A. E., & Hallam, S. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000159898.90221.d3 · Cited by 54
Dawson, A., Chodirker, B. N., & Chudley, A. E. (1995) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1995.1057 · Cited by 49
Spencer, K., Ong, C. Y. T., Liao, A. W., Papademetriou, D., & Nicolaides, K. H. (2000) · Prenatal Diagnosis · doi:10.1002/1097-0223(200008)20:8<611::aid-pd881>3.0.co;2-m · Cited by 48
Molecular fragile X screening in normal populations
Spence, W. C., Black, S. H., Fallon, L. A., Maddalena, A., Cummings, E. L., Menapace-Drew, G. F., Bick, D. P., Levinson, G., Schulman, J. D., & Howard‐Peebles, P. N. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960712)64:1<181::aid-ajmg31>3.0.co;2-h · Cited by 46
Lévesque, S., Dombrowski, C., Morel, M., Réhel, R., Côté, J., Bussières, J., Morgan, K., & Rousseau, F. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01237.x · Cited by 46
An epidemiological/genetic study of mental subnormality in Assiut Governorate, Egypt
Temtamy, S. A., Kandil, M. R., Demerdash, A. M., Hassan, W. A., Meguid, N. A., & Afifi, H. H. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb04176.x · Cited by 38
Applicability of a checklist for clinical screening of the fragile X syndrome
Arvio, M., Peippo, M. M., & Simola, K. O. J. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02549.x · Cited by 37
Cosmetic Therapies in Obstetrics and Gynecology Practice: Putting a Toe in the Water?
Laube, D. W. (2008) · Obstetrics and Gynecology · doi:10.1097/gim.0b013e3181862a76 · Cited by 35
The neurochemical basis for the treatment of autism spectrum disorders and Fragile X syndrome
Hampson, D. R., Adusei, D. C., & Pacey, L. K. K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.02.005 · Cited by 34
Geva, E., Yaron, Y., Shomrat, R., Ben‐Yehuda, A., Zabari, S., Peretz, H., Naiman, T., Yeger, H., & Orr‐Urtreger, A. (2000) · Genetic Testing · doi:10.1089/10906570050501524 · Cited by 29
Pilot Fragile X Screening in Normal Population of Taiwan
Tzeng, C., Cho, W.-C., Kuo, P., & Chen, R. M. (1999) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199909000-00008 · Cited by 25
Molecular diagnosis of Fragile X syndrome
Sofocleous, C., Kolialexi, A., & Mavrou, A. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.9.1.23 · Cited by 24
FMR1 alleles in Tasmania: a screening study of the special educational needs population
Rj, M., Holden, J., Zhang, C., Curlis, Y., Slater, H., Burgess, T., Kirkby, K. C., Carmichael, A., Heading, K., & Loesch, D. Z. (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00344.x · Cited by 21
Frequency of Fra X syndrome among institutionalized mentally retarded males in Poland
Mazurczak, T., Bocian, E., Milewski, M. I., Obersztyn, E., Stanczak, H., Bal, J., Szamotulska, K., & Karwacki, M. W. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960712)64:1<184::aid-ajmg32>3.0.co;2-h · Cited by 17
Todorov, T., Тодорова, А., Georgieva, B., et al. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9260-y · Cited by 17
Elbaz, A., Suédois, J., Duquesnoy, M., Beldjord, C., Berchel, C., & Mérault, G. (1998) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.1998.00064.x · Cited by 16
Survey of adolescents with severe intellectual handicap.
Asthana, J. C., Sinha, S., Haslam, J. S., & Kingston, H. M. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.10.1133 · Cited by 15
Puusepp, H., Kahre, T., Sibul, H., Soo, V., Lind, I., Raukas, E., & Õunap, K. (2008) · Journal of Child Neurology · doi:10.1177/0883073808319071 · Cited by 15
Drasinover, V., Ehrlich, S., Magal, N., Taub, E., Libman, V., Shohat, T., Halpern, G. J., & Shohat, M. (2000) · American Journal of Medical Genetics · Cited by 14
Prevalence of fragile X syndrome among school-age Egyptian males
Meguid, N. A., Raouf, E. R. A., Dardir, A. A., & Awady, M. K. E. (2007) · Cited by 12
Cited by
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838
A guide for the diagnosis of rare and undiagnosed disease: beyond the exome
Marwaha, S., Knowles, J. W., & Ashley, E. A. (2022) · Genome Medicine · doi:10.1186/s13073-022-01026-w · Cited by 359
Fragile X-associated tremor/ataxia syndrome — features, mechanisms and management
Hagerman, R. J., & Hagerman, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.82 · Cited by 290
Berry-Kravis, E., Des Portes, V., Hagerman, R., Jacquemont, S., Charles, P., Visootsak, J., Brinkman, M., Rerat, K., Koumaras, B., Zhu, L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aab4109 · Cited by 270
Profiling the genome-wide landscape of tandem repeat expansions
(2019) · doi:10.1093/nar/gkz501 · Cited by 270
Metadata
- Authors
- Hunter, J., Rivero‐Arias, O., Angelov, A., Kim, E., Fotheringham, I., & Leal, J.
- Venue
- American Journal of Medical Genetics Part A
- Publisher
- Wiley
- Published
- 2014-04-03
- Volume
- 164
- Issue
- 7
- Pages
- 1648-1658
- ISSN
- 1552-4825 (ISSN-L)
- 1552-4833
- OpenAlex
- W1994817684
- Cited by
- 442
- References
- 75
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.